Resource utility
The unavailability of neuronal tissue of patients hampers AS research. iPSC lines reprogrammed from patient cells and differentiated into neurons in vitro are an alternative. AS can arise from different genetic and epigenetic causes and it is of interest to establish iPSC lines covering all possible causes, including imprinting defects. A. Neureiter et al. Stem Cell Research 33 (2018) 20-24 
Resource details
The patient whose fibroblasts were used for reprogramming was diagnosed with AS caused by an imprinting defect. An imprinting defect constitutes as biparental origin of genetically intact chromosomes 15 but lack of DNA methylation at the relevant imprinting center (Horsthemke and Buiting, 2008) . Patient fibroblasts were derived from a skin biopsy and reprogrammed by introduction of episomal vectors expressing L-MYC, LIN28, SOX2, KLF4, OCT3/4 and shRNA against p53. A total of 7 clonal iPSC lines were derived, and one line was characterized in detail. Consistent with the patient's initial diagnosis, chromosome 15 specific MS-MLPA and microsatellite analysis of genomic DNA from patient blood and fibroblasts and the derived iPSCs confirmed absence of deletions, DNA methylation at the imprinting center and biparental origin of chromosomes 15 (Fig. 1A) . MS-MLPA allows simultaneous analysis of copy-number changes and DNA methylation. Briefly, MLPA probes hybridize to genomic DNA and adjacent probes are ligated before they can be amplified by PCR. For detection of DNA methylation, genomic DNA is first digested with a methylationsensitive restriction enzyme. Absence of DNA methylation results in failure of amplification. Normal levels of gene dosage display with a peak ratio of around one (Fig. 1A) . A normal DNA methylation result on the chromosome 15 imprinting center is indicated by a peak ratio of respective probes of 0.5, indicating a level of 50% DNA methylation. Fig. 1A shows loss of DNA methylation at chromosome 15, indicated by the probes residing on baseline. RNA expression of UBE3A was proven by quantitative real-time PCR and comparable to published control iPSC lines #42 and #645 ( Fig. 1B ; expression normalized to GAPDH and calibrated to iPSC line #42; Stanurova, 2016) . Karyotype analysis in passage 27 revealed a female karyotype of 46, XX (Fig. 1C) . Pluripotency of the generated AS_ID iPSC line was demonstrated by qualitative immunofluorescence for expression of nuclear marker proteins OCT4, SOX2 and NANOG and by quantitative FACS analysis of SSEA4 and TRA1-60 surface marker protein expression ( Fig. 1D ; IF: marker proteins in red, nuclei in blue, scale bar 100 μm; FACS: isotype control (grey), sample (black), percentage of positive cells is indicated). Differentiation potential of AS_ID iPSCs was confirmed by embryoid body formation and immunofluorescence for expression of germ line marker proteins, TUJ1 (ectoderm), smooth muscle actin (SMA, mesoderm) and α-fetoprotein (AFP, endoderm) (Fig. 1E , marker proteins in red, nuclei in blue, scale bar 100 μm). Expression of several marker genes in embryoid bodies was additionally analysed by qRT-PCR ( Fig. 1F ; expression normalized to GAPDH and calibrated to d0 of differentiation). Single-cell quantitative analysis of directed differentiation was analysed by FACS for expression of PAX6 (ectoderm), T (mesoderm) and SOX17 (endoderm) ( Fig. 1G ; isotype control (grey), sample (black), percentage of positive cells is indicated). 19% of cells were positive for ectodermal, almost 100% for mesodermal and 73% for endodermal marker protein expression. Although success of ectodermal differentiation was low, we successfully use these cells for neuronal differentiation (data not shown), proving that this cell line is able to differentiate into the ectodermal lineage.
Materials and methods

Reprogramming and cell culture
Human dermal fibroblasts (< P5) isolated from patient's skin biopsy were reprogrammed as described (Okita et al., 2011) . 1.5 μg of each episomal plasmid (Addgene; pCXLE-hUL (#27080), pCXLE-hSK (#27078), pCXLE-hOCT3/4-shp53F #27077) were electroporated into 1 × 10 6 cells using the Neon Transfection System (100 μl tips; 10 ms, 1650 V, 3 pulses; Thermo Fisher). Transfected cells were seeded onto mouse feeder cells in fibroblast medium (DMEM/10% FBS, 2 mM Lglutamine). Medium was switched to TeSR-E7 (Stemcell Technologies) two days post transfection. Established cell line was cultured on Vitronectin-coated plates in StemMACS™ iPS-Brew (Miltenyi Biotec). Cells were passaged every 5 to 6 days using Cell Dissociation Buffer or ReLeSR (Stemcell Technologies).
MS-MLPA
Gene dosage and DNA methylation analysis was performed by methylation-sensitive multiplex-ligation probe amplification using the SALSA MLPA ME028 Prader-Willi/Angelman probemix, according to instructions (MRC Holland). Fragment length analysis was performed on an ABI Genetic Analyzer 3130XL using the program GeneMarker (Softgenetics) Table 1.
qRT-PCR
RNA was isolated using the RNeasy mini kit and 500 ng of RNA was A. Neureiter et al. Stem Cell Research 33 (2018) 20-24 reverse transcribed using the Quantitect Reverse Transcription Kit (Qiagen). qRT-PCR was performed with Quantitect SYBR-Green and analysed with BioRad CFX-Manager Software. Mean and standard deviation of technical triplicates are shown. Primer sequences are listed in Table 2 .
Karyotype analysis
Metaphase chromosomes were prepared as described (Stanurova et al., 2016) , chromosome number was analysed in eleven metaphase spreads and three detailed karyotypes were made.
Immunofluorescence
Cells were grown on Vitronectin-coated cover slips (Matrigel for EBs), fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.1% Triton-X-100 for 10 min, blocked in PBS/5% BSA for 60 min (all at room temperature) and incubated with primary antibodies on 4°C over night. Secondary antibody staining was performed for 60 min at room temperature. Images were taken with a Zeiss Axiovert A1 microscope with Axiovision software. Antibodies (Table 2) were diluted in PBS/5% goat serum.
FACS analysis
A single cell suspension was passed through a 40 μm cell strainer. For intracellular epitopes, cells were fixed in 4% paraformaldehyde for 20 min and permeabilized with 0.1% Triton-X-100 for 15 min. Antibody staining was performed in PBS/10% FCS. Cells were measured on a CytoFLEX flow cytometer using the program CytExpert (Beckman Coulter), plots: X-axis: fluorescence intensity, y-axis: counts. Antibodies are listed in Table 2 .
Germ layer in vitro differentiation
Cells were dissociated with ReLeSR (Stemcell Technologies) as multicellular clusters and seeded on a 6-well-ultra low attachment plate in 50% StemMACS™ iPS-Brew/50% DMEM-F12 + GlutaMax. Next day, medium was changed to DMEM-F12 + Glutamax, 20% FBS, 1% MEM-NEAA, 0,2% β-Mercaptoethanol. On day 7, embryoid bodies were transferred to matrigel-coated dishes or coverslips and cultivated for another 7 days. Medium was changed every other day. For directed monolayer differentiation the STEMDiff Trilineage Kit (Stemcell Technologies) was used according to manufacturer's instructions.
STR and GeneScan analysis
For STR analysis, the Powerplex 16 HS system (Promega) was used 
